Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use
Towards achieving the goal of eliminating epidemic outbreaks of meningococcal disease in the African meningitis belt, a pentavalent glycoconjugate vaccine (NmCV-5) has been developed to protect against <i>Neisseria meningitidis</i> serogroups A, C, Y, W and X. MenA and X polysaccharides...
| Published in: | Pathogens |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/10/8/928 |
